Literature DB >> 15667963

Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis.

Nancy N Baxter1, Arden M Morris, David A Rothenberger, Joel E Tepper.   

Abstract

PURPOSE: To determine the impact of preoperative radiotherapy (RT) on the accuracy of lymph node staging (LNS). Preoperative RT is a well-established component of rectal cancer treatment but its impact on LNS is unknown. METHODS AND MATERIALS: The Surveillance, Epidemiology and End Results (SEER) registry, representing 14% of the U.S. population, was used to assess the impact of preoperative RT on LNS. Our study population consisted of adults with rectal cancer between 1998 and 2000 who underwent radical resection.
RESULTS: In our 3-year study period, 5647 patients met the selection criteria and 1034 (19.5%) underwent preoperative RT. The preoperative RT group was younger (average age, 61 years) than those who did not undergo preoperative RT (average age, 69 years) and more likely to be male (22% of men vs. 16% of women). On average, fewer nodes were examined in patients who underwent preoperative RT (7 nodes) vs. those who did not (10 nodes); this difference was statistically significant, controlling for potential confounders (p < or = 0.0001). In 16% of the preoperative RT patients (vs. 7.5% without), no nodes were identified (p < or = 0.0001). If one used a minimum of 12 nodes as the standard, only 20% of patients who underwent preoperative RT underwent adequate LNS.
CONCLUSION: Lymph node staging in patients who undergo preoperative RT must be interpreted with caution. Studies are needed to evaluate the clinical relevance of node number and pathologic staging after preoperative RT for rectal cancer.

Entities:  

Mesh:

Year:  2005        PMID: 15667963     DOI: 10.1016/j.ijrobp.2004.06.259

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  60 in total

1.  Lymph node harvest in colon and rectal cancer: Current considerations.

Authors:  James R McDonald; Andrew G Renehan; Sarah T O'Dwyer; Najib Y Haboubi
Journal:  World J Gastrointest Surg       Date:  2012-01-27

2.  Laparoscopic proctectomy after neoadjuvant therapy: safety and long-term follow-up.

Authors:  Molly M Cone; Kim C Lu; Daniel O Herzig; Jennifer D Rea; Brian S Diggs; Samuel C Oommen
Journal:  Surg Endosc       Date:  2010-12-24       Impact factor: 4.584

3.  Reduced lymph node yield in rectal carcinoma specimen after neoadjuvant radiochemotherapy has no prognostic relevance.

Authors:  Dietrich Doll; Ralf Gertler; Matthias Maak; Jan Friederichs; Karen Becker; Hans Geinitz; Monika Kriner; Hjalmar Nekarda; Jörg R Siewert; Robert Rosenberg
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.352

Review 4.  EURECCA consensus conference highlights about colorectal cancer clinical management: the pathologists expert review.

Authors:  P Quirke; N P West; I D Nagtegaal
Journal:  Virchows Arch       Date:  2014-01-24       Impact factor: 4.064

5.  Prognostic value of lymph node ratio in survival of patients with locally advanced rectal cancer.

Authors:  Di Zhou; Ming Ye; Yongrui Bai; Ling Rong; Yanli Hou
Journal:  Can J Surg       Date:  2015-08       Impact factor: 2.089

6.  Metastatic lymph node ratio as a prognostic factor after laparoscopic total mesorectal excision for extraperitoneal rectal cancer.

Authors:  Marco Ettore Allaix; Alberto Arezzo; Paola Cassoni; Massimiliano Mistrangelo; Giuseppe Giraudo; Mario Morino
Journal:  Surg Endosc       Date:  2012-12-18       Impact factor: 4.584

7.  Patterns of use and outcomes for radiation therapy in the Quality Initiative in Rectal Cancer (QIRC) trial.

Authors:  Valerie Francescutti; Angela Coates; Lehana Thabane; Charles H Goldsmith; Mark N Levine; Marko Simunovic
Journal:  Can J Surg       Date:  2013-12       Impact factor: 2.089

8.  Prognostic implications of the number of retrieved lymph nodes of patients with rectal cancer treated with preoperative chemoradiotherapy.

Authors:  In Ja Park; Chang Sik Yu; Seok-Byung Lim; Yong Sik Yoon; Chan Wook Kim; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

9.  Stage II/III rectal cancer with intermediate response to preoperative radiochemotherapy: do we have indications for individual risk stratification?

Authors:  Thilo Sprenger; Hilka Rothe; Klaus Jung; Hans Christiansen; Lena C Conradi; B Michael Ghadimi; Heinz Becker; Torsten Liersch
Journal:  World J Surg Oncol       Date:  2010-04-13       Impact factor: 2.754

10.  Preoperative chemoradiotherapy does not necessarily reduce lymph node retrieval in rectal cancer specimens--results from a prospective evaluation with extensive pathological work-up.

Authors:  Thilo Sprenger; Hilka Rothe; Kia Homayounfar; Tim Beissbarth; B Michael Ghadimi; Heinz Becker; Torsten Liersch
Journal:  J Gastrointest Surg       Date:  2009-10-15       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.